DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,809,869 | +244.1% | 27,019 | +262.4% | 0.19% | +233.9% |
| Q4 2022 | $1,978,972 | -52.3% | 7,456 | -45.3% | 0.06% | -83.0% |
| Q3 2021 | $4,148,000 | +404.6% | 13,626 | +344.9% | 0.33% | +378.3% |
| Q2 2021 | $822,000 | -84.2% | 3,063 | -86.9% | 0.07% | -87.5% |
| Q4 2020 | $5,190,000 | +155.3% | 23,365 | +59.1% | 0.55% | +271.6% |
| Q1 2020 | $2,033,000 | -50.9% | 14,687 | -65.0% | 0.15% | -48.4% |
| Q2 2018 | $4,142,000 | +15.7% | 41,978 | +14.8% | 0.29% | +15.3% |
| Q1 2018 | $3,579,000 | +226.3% | 36,551 | +181.2% | 0.25% | -17.0% |
| Q2 2017 | $1,097,000 | -23.7% | 13,000 | -22.6% | 0.30% | +63.0% |
| Q1 2017 | $1,437,000 | -25.9% | 16,800 | -32.5% | 0.18% | -40.1% |
| Q4 2016 | $1,938,000 | +197.7% | 24,900 | +200.0% | 0.31% | +111.7% |
| Q3 2016 | $651,000 | -69.2% | 8,300 | -66.5% | 0.14% | -20.3% |
| Q3 2015 | $2,113,000 | +3.7% | 24,800 | +3.3% | 0.18% | -12.5% |
| Q1 2015 | $2,037,000 | +147.8% | 24,000 | +150.0% | 0.21% | +43.4% |
| Q4 2014 | $822,000 | – | 9,600 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |